Yuyu Pharm to work with KRICT on joint development of ischemic vascular drugs

Published: 2004-07-14 06:56:00

Updated: 2004-07-14 06:56:00

Yuyu Pharm said on July 9 it has signed with the Korea Research Institute of Chemical and Technology a strategic agreement to jointly develop new drugs for the treatment of ischemic vascular diseases such as myocardial infarction, ischemia and arrhythmia.

Under the agreement, Yuyu will be allowed to acquire the exclusive licensing and/or re-licensing rights for KRICT's two novel inventions o...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.